141 – Assessment of Preoperative Diagnostic Accuracy of Multidetector-Row Computed Tomography (MDCT) for Resectable Biliary Cancer: Multi-Institutional Validity Study in Japan
Satoshi Nara, Junji Furuse(Kanagawa Prefectural Hospital Organization), Katsuhiko Uesaka(Shizuoka Cancer Center), Hiroshi Wada, Soichiro Morinaga(Kanagawa Prefectural Hospital Organization), Yoshiyasu Ambo(Hokkaido University of Science), Hiroaki Yanagimoto(National Cancer Center Hospital East), Tsutomu Fujii(University of Toyama), Masayuki Ohtsuka(Chiba University), Naohiro Sata(Jichi Medical University), Etsuro Hatano(Kyoto University), K Sugimachi(National Hospital Organization Kyushu Cancer Center), Masaru Konishi(Shizuoka Cancer Center), Kazuhisa Takeda(Yokohama City University), Hiroaki Nagano(Kyushu University), Michiaki Unno(Tohoku University), Satoshi Hirano, Koji Ohta(Hiroshima University), Kazuaki Shimada(Japan Aerospace Exploration Agency), Munenori Tahara(Sapporo Kosei General Hospital), Tatsuya Nomura, Hirohiko Sakamoto(Saitama Cancer Center), Tetsuo Ohta(Kanazawa University), Yasuhiro Fujino(Hyogo Prefectural Cancer Center), Hirofumi Shirakawa(Shizuoka Cancer Center), Atsushi Miyamoto(Osaka University)
Cited by 2
Related Papers
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
|NEJM Evidence|2022|1.4k
The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective
|The Oncologist|2010|977
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
|Nature Genetics|2014|780
Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan
|British Journal of Cancer|2010|749